JP2009520692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009520692A5 JP2009520692A5 JP2008544003A JP2008544003A JP2009520692A5 JP 2009520692 A5 JP2009520692 A5 JP 2009520692A5 JP 2008544003 A JP2008544003 A JP 2008544003A JP 2008544003 A JP2008544003 A JP 2008544003A JP 2009520692 A5 JP2009520692 A5 JP 2009520692A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- cancer
- group
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000001072 heteroaryl group Chemical group 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 18
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 14
- 125000003107 substituted aryl group Chemical group 0.000 claims 14
- 150000002431 hydrogen Chemical class 0.000 claims 12
- 201000011510 cancer Diseases 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 10
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 4
- 150000004677 hydrates Chemical class 0.000 claims 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 4
- 230000003287 optical effect Effects 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 206010009944 Colon cancer Diseases 0.000 claims 3
- 208000029742 colonic neoplasm Diseases 0.000 claims 3
- 201000007270 liver cancer Diseases 0.000 claims 3
- 208000014018 liver neoplasm Diseases 0.000 claims 3
- 206010005949 Bone cancer Diseases 0.000 claims 2
- 208000018084 Bone neoplasm Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- -1 OR 8 Chemical group 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 208000009956 adenocarcinoma Diseases 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 201000010536 head and neck cancer Diseases 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims 2
- 201000000849 skin cancer Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 201000002510 thyroid cancer Diseases 0.000 claims 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 201000003076 Angiosarcoma Diseases 0.000 claims 1
- 206010003571 Astrocytoma Diseases 0.000 claims 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
- 206010004146 Basal cell carcinoma Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 208000005243 Chondrosarcoma Diseases 0.000 claims 1
- 201000009047 Chordoma Diseases 0.000 claims 1
- 208000006332 Choriocarcinoma Diseases 0.000 claims 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
- 208000009798 Craniopharyngioma Diseases 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 206010014967 Ependymoma Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000006168 Ewing Sarcoma Diseases 0.000 claims 1
- 201000008808 Fibrosarcoma Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 208000001258 Hemangiosarcoma Diseases 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010023774 Large cell lung cancer Diseases 0.000 claims 1
- 208000018142 Leiomyosarcoma Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000030289 Lymphoproliferative disease Diseases 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 208000007641 Pinealoma Diseases 0.000 claims 1
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 1
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 1
- 201000000582 Retinoblastoma Diseases 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 201000010208 Seminoma Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 208000008383 Wilms tumor Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 230000005907 cancer growth Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 201000007455 central nervous system cancer Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000006990 cholangiocarcinoma Diseases 0.000 claims 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims 1
- 238000000502 dialysis Methods 0.000 claims 1
- 210000003038 endothelium Anatomy 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 208000006359 hepatoblastoma Diseases 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 210000003630 histaminocyte Anatomy 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 206010073095 invasive ductal breast carcinoma Diseases 0.000 claims 1
- 201000010985 invasive ductal carcinoma Diseases 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 206010024627 liposarcoma Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 201000009546 lung large cell carcinoma Diseases 0.000 claims 1
- 208000037841 lung tumor Diseases 0.000 claims 1
- 208000003747 lymphoid leukemia Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 208000001611 myxosarcoma Diseases 0.000 claims 1
- 208000025189 neoplasm of testis Diseases 0.000 claims 1
- 201000008026 nephroblastoma Diseases 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- 208000004019 papillary adenocarcinoma Diseases 0.000 claims 1
- 210000000578 peripheral nerve Anatomy 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 208000024724 pineal body neoplasm Diseases 0.000 claims 1
- 206010038038 rectal cancer Diseases 0.000 claims 1
- 201000001275 rectum cancer Diseases 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 201000011098 spinal cord lymphoma Diseases 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 0 CC(C*)*=C(*)[C@@](C)(*)C1C(COC*(C)OC)CCC1* Chemical compound CC(C*)*=C(*)[C@@](C)(*)C1C(COC*(C)OC)CCC1* 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74287505P | 2005-12-07 | 2005-12-07 | |
| US77258206P | 2006-02-13 | 2006-02-13 | |
| US83066606P | 2006-07-14 | 2006-07-14 | |
| PCT/IL2006/001409 WO2007066337A2 (en) | 2005-12-07 | 2006-12-07 | Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009520692A JP2009520692A (ja) | 2009-05-28 |
| JP2009520692A5 true JP2009520692A5 (https=) | 2010-01-28 |
Family
ID=38123294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008544003A Pending JP2009520692A (ja) | 2005-12-07 | 2006-12-07 | 改良されたジャスモネート誘導体、医薬組成物及びそれらの使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8247439B2 (https=) |
| EP (1) | EP1968959A2 (https=) |
| JP (1) | JP2009520692A (https=) |
| AU (1) | AU2006322845A1 (https=) |
| BR (1) | BRPI0619551A2 (https=) |
| CA (1) | CA2630666A1 (https=) |
| WO (1) | WO2007066337A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| US20100003346A1 (en) * | 2006-07-10 | 2010-01-07 | Eliezer Flescher | Combination methods of treating cancer |
| EP2121967A2 (en) | 2007-03-15 | 2009-11-25 | Ramot at Tel-Aviv University Ltd. | Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases |
| WO2009120826A1 (en) * | 2008-03-27 | 2009-10-01 | Wyeth | 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof |
| US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
| JP2014506588A (ja) | 2011-02-25 | 2014-03-17 | ナノケア テクノロジーズ インコーポレイテッド | ジャスモナートファミリーの化合物を含む薬学的製剤 |
| KR102023132B1 (ko) | 2011-09-16 | 2019-09-19 | 나노케어 테크놀로지스 인코퍼레이티드 | 자스모네이트 화합물의 조성물 및 이의 용도 |
| MX2017008655A (es) * | 2014-12-31 | 2018-04-10 | Nanocare Tech Inc | Derivados de jasmonato y composiciones de los mismos. |
| WO2017168416A1 (en) | 2016-03-28 | 2017-10-05 | Vidac Pharma Ltd. | Stable pharmaceutical compositions for topical administration and uses thereof |
| US10682346B2 (en) | 2016-11-07 | 2020-06-16 | Vidac Pharma Ltd. | Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses |
| EP4464334A3 (en) | 2016-11-07 | 2025-01-08 | VIDAC Pharma Ltd. | Use of compounds for treating hk2-expressing cancers |
| WO2019135243A1 (en) * | 2018-01-07 | 2019-07-11 | Vidac Pharma Ltd | Methods for preparation of jasmonate compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63122669A (ja) * | 1986-10-25 | 1988-05-26 | メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 複素環状液晶化合物 |
| US5476945A (en) * | 1992-11-17 | 1995-12-19 | Fuji Photo Film Co., Ltd. | Water-soluble methine derivatives of thiazole |
| DE69431135T2 (de) | 1993-11-15 | 2003-03-27 | Mitsui Chemicals, Inc. | Methode zur Herstellung von Taxan-Typ Diterpen und Methode zur Gewinnung von Kulturzellen die Taxan-Typ Diterpen in hohen Ausbeuten herstellen |
| JPH07308196A (ja) * | 1994-05-18 | 1995-11-28 | Mitsui Petrochem Ind Ltd | タキサン型ジテルペンの製造方法 |
| US6861431B2 (en) * | 2001-03-23 | 2005-03-01 | The Board Of Trustees Of The University Of Illinois | Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same |
| US6469061B1 (en) | 2001-04-04 | 2002-10-22 | Ramot University Authority For Applied Research And Industrial Development Limited | Jasmonate pharmaceutical composition for treatment of cancer |
| FR2825926A1 (fr) * | 2001-06-14 | 2002-12-20 | Sod Conseils Rech Applic | Derives d'imidazoles modulant les canaux sodiques |
| AU2003296405A1 (en) | 2003-01-06 | 2004-08-10 | Eli Lilly And Company | Fused heterocyclic derivatives as ppar modulators |
| WO2005054172A2 (en) | 2003-12-02 | 2005-06-16 | Ramot At Tel-Aviv University Ltd. | Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof |
-
2006
- 2006-12-07 BR BRPI0619551-2A patent/BRPI0619551A2/pt not_active IP Right Cessation
- 2006-12-07 AU AU2006322845A patent/AU2006322845A1/en not_active Abandoned
- 2006-12-07 WO PCT/IL2006/001409 patent/WO2007066337A2/en not_active Ceased
- 2006-12-07 CA CA002630666A patent/CA2630666A1/en not_active Abandoned
- 2006-12-07 US US12/096,111 patent/US8247439B2/en not_active Expired - Fee Related
- 2006-12-07 EP EP06821627A patent/EP1968959A2/en not_active Withdrawn
- 2006-12-07 JP JP2008544003A patent/JP2009520692A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101170655B1 (ko) | 세포 증식 질환 치료용 화합물 | |
| JP2013199483A5 (https=) | ||
| JP2009520692A5 (https=) | ||
| KR20060136398A (ko) | 세포 증식 질환 치료용 화합물 | |
| JP2013521281A5 (https=) | ||
| JP2013538213A5 (https=) | ||
| US20100266674A1 (en) | L-oddc prodrugs for cancer | |
| RU2013109143A (ru) | Бензимидазол- и азабензимидазолсодержащие соединения, которые ингибируют киназу анапластической лимфомы | |
| JP2009530392A5 (https=) | ||
| EP3119781B1 (en) | Compounds which inhibit rna polymerase, compositions including such compounds, and their use | |
| JP2011510028A5 (https=) | ||
| JP2009519907A5 (https=) | ||
| CN103709122B (zh) | 用于治疗的抗肿瘤和抗真菌化合物 | |
| CN101371838B (zh) | 甲基莲心碱及其类似物的新用途 | |
| JP4162994B2 (ja) | 諸疾患状態の処置のための薬物に使用する化合物とその製造方法 | |
| CA2836915A1 (en) | Emetine derivatives, prodrugs containing same, and methods of treating conditions using same | |
| CN114209701A (zh) | 沃替西汀及其衍生物的抗肿瘤活性和应用 | |
| EA003860B1 (ru) | КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА | |
| CN101371839A (zh) | 双苄基异喹啉类生物碱的新用途 | |
| EP3228650B1 (en) | Novel peg derivative | |
| US20120283280A1 (en) | Imidazotetrazinone-based combi-molecules | |
| US20160102066A1 (en) | Benzothiazole derivative and anti-tumor use thereof | |
| RU2007103300A (ru) | Тетрагидрохинолины | |
| JP4018854B2 (ja) | 抗悪性腫瘍薬 | |
| CN102319247A (zh) | 一种靶向于mir-26a的抗肿瘤小分子化合物 |